---
schema_version: "secwatch.filing_event.v1"
accession: "0001214659-22-009675"
form_type: "8-K"
ticker: "ALZN"
cik: "0001677077"
company_name: "Alzamend Neuro, Inc."
filed_at: "2022-08-05T23:59:59+00:00"
generated_at: "2026-06-24T03:23:08.200066+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Alzamend Neuro CFO Lien Escalona resigns; COO David Katzoff appointed as new CFO

## Summary
- Lien Escalona resigned as CFO effective August 1, 2022.
- David J. Katzoff, previously COO, appointed CFO on August 5, 2022.
- Katzoff joined Alzamend in Nov 2019 as SVP Operations, then COO from Dec 2020.
- Katzoff also serves as SVP Finance of BitNile Holdings and CFO of Imperalis Holding Corp.
- No employment agreement or compensation change for Katzoff at this time.

## SEC filing metadata
- accession: 0001214659-22-009675
- form_type: 8-K
- ticker: ALZN
- cik: 0001677077
- company_name: Alzamend Neuro, Inc.
- filed_at: 2022-08-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/0001214659-22-009675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/e842248k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001214659-22-009675
- JSON: https://secwatch.observer/filing/0001214659-22-009675.json
- Plain text: https://secwatch.observer/filing/0001214659-22-009675.txt

## Key facts
- Executive change
  David J. Katzoff was appointed as Chief Financial Officer at Alzamend Neuro, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On August 5, 2022, the Company appointed David J. Katzoff, who has been serving as the Company’s Chief Operating Officer, as its new Chief Financial Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/0001214659-22-009675-index.htm
- Executive change
  Lien Escalona resigned as Chief Financial Officer at Alzamend Neuro, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On August 1, 2022, Lien Escalona resigned as the Chief Financial Officer of Alzamend Neuro, Inc. (the “Company”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1677077/000121465922009675/0001214659-22-009675-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.